304 related articles for article (PubMed ID: 10467133)
21. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
Huang WC; Chen JJ; Inoue H; Chen CC
J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
Hawkins J; Marcy A
Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
[TBL] [Abstract][Full Text] [Related]
24. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
25. Design of allele-specific inhibitors to probe protein kinase signaling.
Bishop AC; Shah K; Liu Y; Witucki L; Kung C; Shokat KM
Curr Biol; 1998 Feb; 8(5):257-66. PubMed ID: 9501066
[TBL] [Abstract][Full Text] [Related]
26. Conversion of protein phosphatase 1 catalytic subunit to a Mn(2+)-dependent enzyme impairs its regulation by inhibitor 1.
Endo S; Connor JH; Forney B; Zhang L; Ingebritsen TS; Lee EY; Shenolikar S
Biochemistry; 1997 Jun; 36(23):6986-92. PubMed ID: 9188695
[TBL] [Abstract][Full Text] [Related]
27. The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity.
Scapin G; Patel SB; Lisnock J; Becker JW; LoGrasso PV
Chem Biol; 2003 Aug; 10(8):705-12. PubMed ID: 12954329
[TBL] [Abstract][Full Text] [Related]
28. Src tyrosine kinases and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases mediate pressure-induced c-fos expression in cannulated rat mesenteric small arteries.
Wesselman JP; Dobrian AD; Schriver SD; Prewitt RL
Hypertension; 2001 Mar; 37(3):955-60. PubMed ID: 11244024
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
32. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.
Meng F; Lowell CA
EMBO J; 1998 Aug; 17(15):4391-403. PubMed ID: 9687507
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinases of the Src family participate in signaling to MAP kinase from both Gq and Gi-coupled receptors.
Igishi T; Gutkind JS
Biochem Biophys Res Commun; 1998 Mar; 244(1):5-10. PubMed ID: 9514877
[TBL] [Abstract][Full Text] [Related]
34. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
36. Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Hill ZB; Perera BG; Maly DJ
Mol Biosyst; 2011 Feb; 7(2):447-56. PubMed ID: 21060940
[TBL] [Abstract][Full Text] [Related]
37. Src-family tyrosine kinases, phosphoinositide 3-kinase and Gab1 regulate extracellular signal-regulated kinase 1 activation induced by the type A endothelin-1 G-protein-coupled receptor.
Bisotto S; Fixman ED
Biochem J; 2001 Nov; 360(Pt 1):77-85. PubMed ID: 11695994
[TBL] [Abstract][Full Text] [Related]
38. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
39. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
40. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src).
Wang W; Ramdas L; Sun G; Ke S; Obeyesekere NU; Budde RJ; McMurray JS
Biochemistry; 2000 May; 39(17):5221-8. PubMed ID: 10819990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
